Evidence map›Paper›PMID 7501476›Full record

ArticleNucleic acids research1995

Tissue-specific in vivo protein-DNA interactions at the promoter region of the Xenopus 63 kDa keratin gene during metamorphosis.

D Warshawsky, L Miller

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

D WarshawskyDepartment of Biological Sciences, University of Illinois at Chicago 60607, USA.
L Miller
University of Illinois Chicago · US

Funding

KERATIN GENE EXPRESSION DURING XENOPUS DEVELOPMENTR01HD024438 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MILLER, LEO · 1988 to 1992
–
NICHD NIH HHS HD 24438
6 · The paper itself

Abstract

The Xenopus 63 kDa keratin gene is developmentally regulated and is expressed only in the epidermis. Full activation of the 63 kDa keratin gene requires two regulatory steps, the first independent and the second dependent on the thyroid hormone triiodothyronine (T3). Sequence analysis of a genomic clone of the 63 kDa keratin gene identified potential AP2 and SP1 binding sites upstream of the transcription initiation site. Electrophoretic mobility shift assays using purified or enriched proteins, as well as HeLa nuclear extract in conjunction with AP2- and SP1-specific antibodies, have been used to demonstrate that human AP2 and SP1 bind elements upstream of the transcription initiation site. In vivo footprinting with ligation mediated PCR revealed several footprints, within 350 bp upstream of the transcription initiation site, including those at the AP2 and SP1 sites, that are unique to epidermal cells which express the keratin gene. These footprints were absent in blood cells and XL177 cells which do not express the gene. Comparison of footprints between cells which express the 63 kDa keratin gene at low or high levels showed that the same binding sites are occupied, indicating that these sites are required for basal as well as T3-induced expression of the 63 kDa keratin gene.

Indexed as

Promoter Regions, GeneticAnimalsBase SequenceBinding SitesCell Membrane PermeabilityDNA-Binding ProteinsDNA FootprintingEpidermisHeLa CellsHumansKeratinsMetamorphosis, BiologicalMolecular Sequence DataPolymerase Chain ReactionProtein BindingSp1 Transcription FactorDNA-Binding ProteinsKeratinsSp1 Transcription Factortfap2a protein, XenopusTranscription Factor AP-2Transcription FactorsTriiodothyronineXenopus Proteins

Identifiers

PMID7501476
PMCPMC307410
OpenAlexW2016781876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.